Physician

Todd L. Hostetler, M.D.

According to 2025 Medicare claims, Todd Hostetler, M.D. (NPI: 1619015088) practices allergy/immunology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ENT & ALLERGY ASSOCIATES, S.C. (NPI: 1255384301; TIN: 391133811) and primary practice location at 54401-4147. Hostetler is affiliated with the Gundersen ACO (ACO ID: A5094), participating under the MSSP model.

Hostetler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 7,752 HCPCS/CPT codes, and received $194,325 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,264 prescription claims across 231 beneficiaries totaling $539,043 in drug costs, led by Fasenra Pen (Benralizumab). DME data shows 91 claims. Open Payments data shows 7 records totaling $148. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $19,227 to $194,325. Similarly, Part D prescription costs have moved sharply higher in recent years, from $99,686 to $539,043. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	1,565	$19,227
2016	107	2,358	$31,332
2017	105	2,547	$28,539
2018	142	3,439	$60,580
2019	195	6,337	$147,030
2020	185	5,639	$161,262
2021	183	5,315	$142,474
2022	189	5,680	$166,902
2023	166	6,850	$182,933
2024	170	7,752	$194,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	73	326	$99,686
2016	74	397	$44,796
2017	99	408	$57,206
2018	108	539	$87,161
2019	165	818	$147,575
2020	177	1,039	$176,502
2021	205	948	$221,253
2022	201	998	$297,258
2023	200	1,102	$407,077
2024	231	1,264	$539,043

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	85	$140,970
2019	N/R	147	$241,519
2020	N/R	143	$223,269
2021	N/R	84	$197,478
2022	N/R	91	$213,384
2023	N/R	90	$217,307
2024	N/R	91	$237,455

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	59	80	$78
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	42	42	$71
95012	Test to measure the level of nitric oxide gas	44	52	$12
95024	Test for allergy using allergenic extract injected into skin	42	452	$6
95004	Test for allergy using allergenic extract	45	1,755	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fasenra Pen	Benralizumab	26	1,400	$150,837
Dupixent Pen	Dupilumab	30	840	$114,782
Advair Hfa	Fluticasone Propion/Salmeterol	91	4,590	$57,102
Spiriva Respimat	Tiotropium Bromide	44	2,430	$41,484
Breo Ellipta	Fluticasone/Vilanterol	66	2,520	$33,669

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	27	$160,590
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	14	$74,413
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	25	$2,056
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	25	$397

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$148	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd L. Hostetler, M.D.?

Tedicare shows public-source Medicare data for Todd L. Hostetler, M.D. (NPI 1619015088), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd L. Hostetler, M.D. have ACO affiliation data?

Todd L. Hostetler, M.D. is shown with ACO affiliation data for Gundersen ACO (MSSP, ACO ID A5094).

What billing organization is linked to Todd L. Hostetler, M.D.?

Todd L. Hostetler, M.D. is linked to ENT & ALLERGY ASSOCIATES, S.C. (billing NPI 1255384301) in the available physician profile data.

Does Todd L. Hostetler, M.D. have Open Payments data?

Todd L. Hostetler, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.